Trademarkia Logo

Canada

C$
Trademark Search in Canada
MAZE

View On IC.GC.CA

MAZE
FORMALIZED

on 18 Jun 2025

Last Applicant/ Owned by

Maze Therapeutics, Inc.

171 Oyster Point Boulevard, Suite 300South San Francisco CA 94080

US

Serial Number

2406331 filed on 21st Apr 2025

MAZE

Trademark usage description

diagnostic preparations for scientific or research use other than for medical use; assays and reagents for scientific or medical research use; genetic Read More

Classification Information

Class [001]
Diagnostic preparations for scientific or research use other than for medical use; assays and reagents for scientific or medical research use; genetic testing preparations for scientific or medical research use, namely, assays and reagents for use in genetic and biomedical research; cells for scientific or medical research use.

Classification kind code

12

Class [005]
Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; pharmaceutical preparations for treating genetic diseases and disorders; pharmaceutical preparations for treating and lysosomal storage disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the reproductive system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart diseases and disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases and disorders; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in urology; pharmaceutical preparations for the prevention and treatment of obesity; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical products for the prevention and treatment of bone diseases; pharmaceutical products for the prevention and treatment of respiratory diseases and asthma; reagents for medical use; genetic testing preparations for medical purposes, namely, medical diagnostic reagents and assays for testing of body fluids, cells, and tissue; cells for medical or clinical use; medical diagnostic and testing assays, namely, medical diagnostic reagents and assays for testing of body fluids, cells, and tissue.

Classification kind code

12

Class [042]
Pharmaceutical research and development services; research in the field of genetic modifiers and related therapeutics; research in the field of genetic variations linked to medical diseases or conditions; research in the field of variant functionalization.

Classification kind code

12

Mark Details

Serial Number

2406331

Mark Type

Trademark

Legal History

Action TakenStatus
Submitted for opposition 257
on 19th Jun 2025		Designation Notification - Madrid Protocol
Submitted for opposition 1
on 18th Jun 2025		Created
Submitted for opposition 31
on 18th Jun 2025		Formalized
Submitted for opposition 30
on 21st Apr 2025		Filed
Submitted for opposition 228
on 21st Apr 2025		International Registration